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OBJECTIVES: The purpose is to study the effects of hyperbaric oxygen therapy and autologous platelet
concentrates in healing the fibula bone of rabbits after induced fractures.
METHODS: A total of 128 male New Zealand albino rabbits, between 6–8 months old, were subjected to a total
osteotomy of the proximal portion of the right fibula. After surgery, the animals were divided into four groups
(n=32 each): control group, in which animals were subjected to osteotomy; autologous platelet concentrate
group, in which animals were subjected to osteotomy and autologous platelet concentrate applied at the fracture
site; hyperbaric oxygen group, in which animals were subjected to osteotomy and 9 consecutive daily hyperbaric
oxygen therapy sessions; and autologous platelet concentrate and hyperbaric oxygen group, in which animals
were subjected to osteotomy, autologous platelet concentrate applied at the fracture site, and 9 consecutive daily
hyperbaric oxygen therapy sessions. Each group was divided into 4 subgroups according to a pre-determined
euthanasia time points: 2, 4, 6, and 8 weeks postoperative. After euthanasia at a specific time point, the fibula
containing the osseous calluswas prepared histologically and stainedwith hematoxylin and eosin or picrosirius red.
RESULTS: Autologous platelet concentrates and hyperbaric oxygen therapy, applied together or separately,
increased the rate of bone healing compared with the control group.
CONCLUSION: Hyperbaric oxygen therapy and autologous platelet concentrate combined increased the rate of
bone healing in this experimental model.
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& INTRODUCTION
Loss of osseous continuity due to fracture is a disabling
condition, even momentarily, that often deprives the
individual of his or her social and professional lifestyle.
Therefore, as a medical specialty, orthopedics has invested
in studies that promote reduced bone healing time and,
consequently, reduced time required to return to normal or
almost normal function.
Although most fractures do not present healing problems
under normal conditions, in some situations, the poorly
vascularized bone tissue does not respond adequately to
treatment, resulting in delayed consolidation or non-
consolidation (1). Thus, developing new techniques to help
the bone healing process and stimulate fracture consolida-
tion is very important.
Several studies have focused on reducing bone healing
time using low-intensity pulsed ultrasound, low-energy
lasers, electrical stimulation, and platelet-rich concentrates
(2).
Platelet-rich concentrate (PRC) is an autologous concen-
tration of platelets that releases growth factors. Platelets and
the release of these proteins are essential for clot formation
in the physiological process of tissue repair. A normal clot
consists of 95% red blood cells, 4% platelets, and 1% white
blood cells. However, an analysis of platelet-enriched clots
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reveals 95% platelets, 4% red blood cells, and 1% white
blood cells (2).
Platelet-derived growth factor (PDGF) has defined peri-
ods of activity. PDGF is a major factor during the onset of
tissue repair and acts directly on cell differentiation and
angiogenesis. According to classic studies by Heldin &
Westmark (3), PDGF is the first growth factor that initiates
repair by stimulating mitogenesis and increasing the local
populations of mesenchymal stem cells and osteoprogenitor
cells. At concentrations of 20 to 100 ng/ml, bone formation
and alkaline phosphatase activity increase in the deminer-
alized matrices of rats (4).
Transforming growth factor beta (TGF-b) is a cytokine
synthesized in bone tissue and platelets that stimulates the
proliferation of osteoblast precursor cells, promotes collagen
synthesis, increases the number of cells that express the
osteoblast genotype, increases osteoclast apoptosis, and
activates endothelial cells for angiogenesis and chondro-
progenitor cells in cartilage formation. However in vitro,
TGF-b alone does not induce bone formation in an animal
model (5).
Methods for obtaining platelet growth factors should
consider the platelet concentrate rate, processing technique,
concentration of secreted proteins, handling and applica-
tion, and especially the clinical application (6). Platelet-rich
plasma (PRP) is undoubtedly the most widely used serum;
however, its indiscriminate use has been criticized, and it is
still not approved by the Food and Drug Administration
(FDA) (7).
Autologous platelet concentrate (APC) is a platelet-rich
concentrate (PRC) that is similar to PRP but has certain
methodological advantages in terms of how it is obtained. In
addition to being approved by the FDA (using the double-
syringe method), APC can be withdrawn and used during a
surgical procedure for fracture fixation and is easily
processed in a few minutes, which is important because
PDGF and TGF-b have half-lives of only a few minutes
outside the vascular system (7).
The basic difference between PRP and APC is that PRP is
an PRC, with a platelet concentration over 2 times greater
than that of plasma. APC is a PRC that combines PRP with
platelet-poor plasma (PPP); according to the manufacturer,
APC contains 2 times the platelet concentration of blood
plasma. According to studies by Graziane et al. (8), this
platelet concentration is sufficient to stimulate osteoblast
proliferation in vitro. In addition, obtaining APC using the
double-syringe method eliminates leukocytes, proteases,
and hydrolases, which may be able to degrade APC (9).
Hyperbaric oxygen therapy (HBO) is another treatment
that may have positive effects on the bone healing process.
According to the Undersea and Hyperbaric Medical
Society, HBO is defined as intermittently inhaling 100%
oxygen inside a chamber at pressures greater than 1
atmosphere absolute (ATA). This therapy has been first-
choice treatment for decompression sickness in divers since
the 1920s; however, only since the 1950s has it been used to
treat gas embolism, carbon monoxide poisoning, gangrene
gas, compartment syndrome, soft tissue infection, osteo-
myelitis, and osteoradionecrosis (10).
The advantage of HBO is that it is a safe treatment.
According to the literature, the complication rate is 1.83%,
of which 94% are considered minor complications.
The disadvantages of HBO include the high cost of the
hyperbaric chamber and the technical training necessary,
considering the number of circumstances under which it can
be used with some level of evidence. However, the delayed
consolidation or non-consolidation of fractures has signifi-
cant financial impacts on society and represents a serious
clinical challenge for which few treatment options are
available. Various, often necessary surgical procedures are
accompanied with patient morbidity and reduced quality of
life (11).
This study was designed to test the hypothesis that many
patients with fractures or delayed consolidations could
benefit from APC, HBO, or a combination of both
treatments because the literature indicates that the osteo-
genic action of growth factors depends directly on the tissue
oxygen tension (12).
& MATERIALS AND METHODS
Sample
This study was approved by the Ethics Committee of
Universidade Federal de Sa˜o Paulo (0163/08). All animals
were handled according to "The Ethical Principles of
Animal Experiments of the International Union for the
Protection of Animals" 11.794/2008 Act of October 8, 2008.
A total of 128 6-8-month-old male New Zealand albino
rabbits (Oryctolagus cuniculus), with an average weight of
3,000 grams, were subjected to an osteotomy of the right
fibula after an adaptation period.
After surgery, the animals were randomized into 4 groups
of 32 rabbits according to the postsurgical treatment used, as
follows:
N Control Group (CG) - animals subjected only to
osteotomy of the right fibula, without further treatment
N APC Group (APCG) - animals subjected to osteotomy of
the right fibula and treated with APC
N HBO Group (HBOG) - animals subjected to osteotomy of
the right fibula and treated with consecutive daily HBO
sessions, totaling 9 sessions
N APC and HBO group (APC+HBOG) - animals subjected
to osteotomy of the right fibula and treated with APC,
combined with consecutive daily HBO sessions, totaling
9 sessions
Each group was further divided into 4 subgroups of 8
animals each, according to a pre-determined euthanasia
time point at 2, 4, 6, and 8 weeks postoperatively.
Operative procedure
All animals were food- and water-fasted for 6 hours pre-
operatively and then weighed; all the fur was shaved at the
leg region.
Pre-anesthesia was induced with ketamine hydrochloride
solution at a dose of 30 mg/kg, xylazine at a dose of 3 mg/
kg, and tramadol hydrochloride at a dose of 5 mg/kg
intramuscularly in the gluteal region.
The animals were anesthetized with spinal anesthesia
using 2% lidocaine without a vasoconstrictor at a dose of
0.5 mg/kg. Venoclysis of the right auricular vein was
performed for the infusion of the necessary drugs.
Antisepsis was then performed with polyvinylpyrrolidone,
and the operative field was isolated with sterile field cloths,
delimiting a restricted area for the surgery.
Then, a 2-cm lateral longitudinal incision was made along
the right leg and dissected by following the muscular planes
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and localization of the fibular diaphyseal region. A complete
transverse osteotomy of the fibula was performed using a
no. 15 scalpel blade at the proximal third of the tibial
tuberosity.
The surgery was completed by suturing the planes,
aponeurosis, subcutaneous tissue, and skin with 4-0 nylon
thread. Tramadol hydrochloride analgesic was adminis-
tered at a dose of 2 mg/kg intramuscularly and maintained
every 12 hours for 3 consecutive days, in combination with
4 intramuscular antibiotic treatments with benzathine
penicillin and G potassium at doses of 20,000 IU/kg every
48 hours, in all animals.
Immediately after the osteotomy of the fibula, the animals
were randomized according to the pre-determined treat-
ment groups under study and to their respective subgroups.
The hind limb did not need to be immobilized because the
distal portion of the fibula in rabbits exhibits fusion with the
tibia.
During the post-operative period, at the pre-determined
time for each subgroup (2, 4, 6, or 8 weeks), the animals
were anesthetized again according to the previous protocol,
and the fibulae were resected, including the osseous callus,
using a no. 15 scalpel blade. Euthanasia was induced during
deep anesthesia with xylazine.
Application of autologous platelet concentrate
This procedure was performed during the surgery. Before
the surgical procedure, 2.5 ml of blood was withdrawn from
the auricular vein using a 10-ml double-syringe (ACP-
double syringe, Arthrex, Naples, FL, USA) containing 0.5 ml
of acid citrate dextrose anticoagulant, and the syringe was
gently agitated to ensure the adequate mixing of the blood
with the anticoagulant. The syringe containing the anti-
coagulated blood was then stored in a suitable tube and
centrifuged (Rotofix 32A, Arthrex, USA) at 1500 RPM for 5
minutes to separate the red blood cells from the plasma.
After centrifugation, the plasma was removed from the
tube using the same syringe, while the internal syringe
collected only the concentrate, leaving the red blood cells.
Using this procedure, which was provided by the manu-
facturer, we obtained approximately 1.5 ml of concentrate,
with a high concentration of autologous platelets enriched
with growth factors.
The platelet concentrate was applied directly to the
fracture (osteotomy) in the proximal third of the rabbit
fibula before closing the muscular fascia.
Hyperbaric oxygen therapy
HBO sessions were conducted using a veterinary hyper-
baric chamber model (AN – 500, Sechrist, USA) with a 14-
rabbit capacity (average weight of 2,500 grams each). The
sessions were conducted daily, 8 animals at a time, and
began on the first post-operative day for 90 minutes at 3
ATA (13). We opted for 9 sessions in the HBO and
APC+HBO groups because the growth factor acts primarily
during the first 7 post-operative days (14).
The beginning of the session included a compression
period. After 15 minutes, the chamber manometer indicated
2 atm of pressure; assuming that the manometer in the
hyperbaric chamber measures the pressure difference
between the chamber and the surrounding environment,
the barometric pressure and environmental pressure (1
ATA) were added to convert the values into absolute
atmospheres (ATA). Therefore, the pressure applied by the
chamber was 3 ATA. This absolute pressure (3 ATA) was
maintained for 60 minutes, followed by decompression for
15 minutes; thus, each session ended after 90 minutes.
Histomorphometric analysis
Immediately after the experiment, the proximal third of
the fibula from each animal, containing the osseous callus
region, was surgically removed and placed in 10% buffered
formalin for 48 hours. After this period, the decalcification
process was begun in ethylenediaminetetraacetic acid
(EDTA); after 6 days, the pieces were dehydrated in
increasing concentrations of ethyl alcohol, diaphanized in
xylene, impregnated in histological paraffin, and embedded
in paraffin.
Paraffin blocks were cut with a Minot microtome (Leica,
Model RM 2145) with semi-serial 4 ı`m cuts. After drying for
6–8 hours in an oven at 60 C˚, some sections were stained
with hematoxylin and eosin (HE), and others were stained
with picrosirius red. The slides were observed under a light
microscope (Carl ZeissH) at 4 to 1006.
To determine the concentration of bone cells (osteocytes,
osteoblasts, and osteoclasts) in the fibula, an 180061600 mM
rectangle was initially determined, drawn using a mouse, in
two central regions adjacent to the healing bone; one was on
the diaphysis side, and the other was on the epiphyseal side.
Then, the cells were individually counted within the
rectangles, excluding cells that touched the rectangles. For
each animal, 6 slides were evaluated. We recorded the
average number of cells counted in the rectangles for each
animal.
The thickness of the cartilage region within the remaining
osseous callus was obtained at 3 points in each slide (6 slides
for each animal) using a mouse. We recorded the average
number of measurements in mM for each animal.
Determining the percentages of collagen
The cuts stained with picrosirius red were used to
determine the percentage of collagen formed. Initially, the
sections were dewaxed in xylene and then hydrated in a
decreasing ethanol gradient. Afterward, elastin was blocked
with 0.2% phosphomolybdic acid for 10 minutes. The
sections were washed in distilled water, immersed in a
0.1% sirius red solution, and dissolved in saturated aqueous
picric acid for 90 minutes. Then, the sections were washed
in 0.01 N HCl for 2 minutes. Later, the sections were
dehydrated in an increasing ethanol gradient, cleared in
xylene, and mounted with EntellanH.
Photomicrographs of the picrosirius red-stained sections
from the rabbit fibulae of different groups were taken under
a polarized light microscope (Axiolab Standard 2.0, Carl
ZeissH) coupled to a high-resolution video camera
(AxionCam, Carl ZeissH) to identify the distribution of
collagen fibers in the bone matrix. Then, the micrographs
were analyzed on a computer with the ImagelabH program.
Statistical analysis
For quantitative variables, descriptive statistics were
calculated. Analysis of variance (ANOVA) and multiple
comparisons by the Tukey test were used as inferential
analyses to either confirm or refute the evidence found in
the descriptive analysis.
For all the results obtained via inferential analyses, a
significance level of a= 5% was used. All statistical analyses
were performed with the R program software, version 2.11.1.
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& RESULTS
Information referring to the percentages of collagen,
numbers of osteoblasts and osteocytes, and lesion thickness
were important measurements assessed among groups and
euthanasia time periods (subgroups). Table 1 and Figure 1
(A – D) summarize the behavior of these measurements
according to the groups and euthanasia periods (subgroup).
Table 2 shows the results of comparisons of the
percentages of collagen, numbers of osteoblasts and
osteocytes, and lesion thicknesses among groups and
euthanasia periods. Figure 2 (A – H) shows the HE slides
from the groups and subgroups (2th and 6th weeks).
& DISCUSSION
The results obtained from this experimental model indicate
a higher rate of bone healing in response to APC combined
with HBO. No previous study in the literature was found to
have used this combination in an experimental study.
Qualitative analysis highlighted the accelerated bone
healing in the APC+HBOG compared with the CG during
all weeks studied; additional data on the percentages of
collagen and lesion thickness confirm this assessment. In
1983, a review article found that low oxygen tension reduced
the action of autologous growth factors (12). Similarly, the
outcomes shown here suggest that the higher oxygen tension
caused by HBO application could potentiate the effects of the
growth factors offered by APC therapy on bone healing.
Although there was no significant difference between the
numbers of osteoblasts during any of the periods studied or
between the number of osteocytes counted during the 2nd
and 8th weeks, relative to the groups treated with APC and
HBO combined, quantitative data on the average lesion
thickness showed that the APCG, HBOG, and APC+HBOG
were superior to the CG. The APC+HBOG was superior to
the other groups across all periods, whereas the HBOG was
superior to the APCG across all periods for this variable.
The fact that PRC use (in this study, APC) led to a
superior rate of bone healing compared with the CG
corroborates the outcomes of other studies. Marx et al. (15)
performed the first and most convincing study using PRP
combined with autogenous bone grafts. The authors
evaluated the effect of PRP on the reconstruction of
mandibular bone defects resulting from tumor removal.
The authors stated that bone grafts with PRP showed more
than double the maturity of the controls.
Another study by Anitua produced excellent outcomes
using autogenous bone grafts combined with PRP (16). The
authors observed a total alveolar bone regeneration in 8 of
10 patients who were treated with PRP and bone graft.
Biopsies of the respective areas showed compact mature
bone with normal morphology and well-organized trabe-
cular regions, while the control patients showed connective
tissue, mostly filled with alveoli, and no mature bone.
However, some studies do not support the effect of PRC
on the rate of bone healing. Recently, Broggini et al. (17)
evaluated bone repairs in the monocortical defects in the
calvaria of 15 New Zealand rabbits. The authors concluded
that PRP, alone or combined with an autogenous graft, did
not lead to a higher rate of bone regeneration compared
with basal clot during the initial healing.
Currently, the literature is more concerned with quantify-
ing the concentration of growth factors present in some of
the most widely used PRCs, especially PRP. A study using
this approach stated that the concentration of growth factors
in PRP can reach up to 7 and 30 times the basal levels of
TGF-b and PDGF, respectively, in a basal clot (18).
According to the manufacturer’s data on the double-syringe
method used in this study, APC can have up to 4 and 25
times the levels of TGF-b and PDGF, respectively. Although
the concentrations of growth factors found in APC were
lower than in PRP, this study demonstrated that this
difference does not seem to be a disadvantage. However,
it is important to note that functional and non-harmful
amounts of these factors in tissue repair have not been well
determined.
Regarding our outcomes on the effect of HBO on the rate
of bone healing, HBO increased the bone consolidation rate
compared with the CG, which could be observed through
Table 1 - Summary measurements (average¡ standard deviation) of the percentage of collagen, number of osteoblasts
and osteocytes, and lesion thickness, according to groups and euthanasia periods (subgroups).
Group Euthanasia period (weeks) No. of osteocytes No. of osteoblasts % of collagen Lesion thickness
CG 2 (n=8) 0.13¡0.35 11.25¡0.89 15.59¡0.33 297.97¡0.02
4 (n= 8) 10.38¡0.52 6.38¡0.52 30.26¡0.27 192.30¡0.10
6 (n= 8) 7.25¡0.46 3.50¡0.53 70.39¡0.16 98.34¡0.18
8 (n= 8) 19.38¡0.74 0.13¡0.35 80.83¡0.28 5.54¡0.24
APCG 2 (n=8) 1.00¡0.00 13.63¡0.52 15.58¡0.29 205.16¡0.02
4 (n= 8) 11.25¡0.71 4.38¡0.52 50.50¡0.31 165.76¡0.28
6 (n= 8) 14.75¡0.71 2.13¡0.35 81.76¡0.28 47.36¡0.13
8 (n= 8) 20.00¡0.76 0.38¡0.52 92.86¡0.55 3.43¡0.28
HBOG 2 (n=8) 1.25¡0.46 12.38¡0.52 19.81¡0.15 198.23¡0.39
4 (n= 8) 10.75¡0.46 2.25¡0.46 45.78¡0.24 164.94¡1.00
6 (n= 8) 16.00¡0.53 1.25¡0.46 83.24¡0.42 34.99¡0.41
8 (n= 8) 20.63¡0.92 0.25¡0.46 90.58¡0.46 1.10¡0.74
APC+HBOG 2 (n=8) 1.38¡0.52 12.75¡0.89 20.91¡0.18 165.45¡0.28
4 (n= 8) 14.75¡0.71 2.00¡0.00 65.38¡0.35 110.41¡0.11
6 (n= 8) 20.00¡0.93 0.38¡0.52 95.06¡0.26 24.62¡0.46
8 (n= 8) 21.13¡1.13 0.00¡0.00 98.00¡0.39 0.25¡0.46
CG: Control Group; APCG: Autologous platelet concentrate Group; HBOG: Hyperbaric oxygen therapy Group; APC+HBOG: Autologous platelet
concentrate plus Hyperbaric oxygen therapy Group.
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the varying percentages of collagen during each week, the
number of osteocytes during the 6th and 8th weeks, and the
lesion thickness across all weeks.
Our search for relevant publications led us to the
observation that the first studies on the effects of HBO on
bone healing date back to the 1960s. After almost 50 years,
there are still few studies on this subject.
In a Cochrane review study (19), the authors concluded
that there is insufficient evidence to support or refute HBO
use for fracture treatment or as a therapy for non-
consolidated fractures within an expected time. This
conclusion was based on 9 potentially relevant articles
among the 68 references identified. However, none of the
articles met the review’s inclusive criteria: any randomized
or quasi-randomized studies that compared clinical results
obtained with HBO use to those obtained without HBO use
(no treatment).
Although the literature did not include clinical results
that met the methodology described above, our outcomes
and the studies cited indicate that HBO is beneficial to the
fracture healing process.
In 1998, Ueng et al. (20) studied bone mineral density and
tensile strength in a rabbit tibial-lengthening model. The
bone segments from HBO-treated animals had higher
mineral densities and superior biomechanical properties
compared with the control animals. Using the same
experimental model, this group obtained similar findings,
showing that HBO is also advantageous during the early
stages of tibial fracture healing (21).
Chen et al. (22) studied the effect of HBO in rabbits subjected
to fusion of the vertebrae with a bone graft. According to these
authors, the incidence of bone non-consolidation for this
procedure in humans ranges from 6–35% of cases and 40–50%
in rabbits. After 8 weeks, the HBO group showed a 100%
consolidation of the fractures, which were identified radi-
ologically and by torsional biomechanical tests.
The vast majority of the studies combining HBO and bone
repair refer to osteoradionecrosis treatment. Radiation
Figure 1 - Distribution of the average percentage of collagen (A), average number of osteoblasts (B) and osteocytes (C), and average
lesion thickness (D), according to groups and euthanasia periods (subgroups).
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therapy results in progressive obliterative endarteritis,
which leads to ischemia and a pathological fracture of the
bone with reduced healing ability (23). Muhonen et al. (24)
evaluated the angiogenic and osteogenic responses after
radiation and HBO in a rabbit mandibular distraction
model. The authors concluded that the HBO group
improved in the bone formation pattern.
Most experimental studies have found a positive effect
from HBO use in the fracture healing process. This effect
may be directly associated with the increased formation of
new vessels, which increases blood inflow and, thereby,
bone formation. Wu et al. (25) presented the outcomes of an
in vitro study that investigated the effects of HBO on the
proliferation and differentiation of human osteoblasts and
concluded that HBO also stimulates initial cell proliferation
and acts directly on osteogenic differentiation in osteoblasts.
Jan et al. (26) presented the results of a study that assessed
the effect of HBO on a rabbit calvaria fracture model. After
radiographic and histomorphometric evaluations of the
lesion after 6 and 12 weeks, the authors concluded that
bone regeneration was significantly improved in the group
of HBO-treated animals. It is noteworthy that the type of
lesion caused in this experiment was considered critical, and
bone healing was unlikely to occur.
Yeh et al. (27) studied the effects of HBO on the
neovascularization of the tendon-bone junction, on the
behavior of collagen fibers within the graft, and on the
incorporation process of the graft into the bone tunnel of
rabbits subjected to knee arthroscopy for the reconstruction
of the anterior cruciate ligament with a tendon graft. The
graft is incorporated into the bone tunnel through callus
formation and the posterior ossification of the tunnel (28). In
the HBO-treated animals, collagen fibers showed greater
organization surrounding the graft and had an early
mineralization of fibrocartilage compared with the control
animals. The biomechanical test also indicated that HBO-
treated animals exhibited greater resistance to the tensile
strength of the graft at 18 weeks post-operation than the
control animals.
The benefits of HBO are related to its proven therapeutic
safety and the possible use of the equipment to treat a wider
range of diseases. Its disadvantages include the high cost of
the equipment and the low level of scientific evidence for
HBO use in treating these diseases (19).
However, in choosing a treatment method, one must
consider many variables, such as the cost of the equipment,
the specialized personnel, the methodological complexity,
and the characteristics of the fracture to be treated. Although
the mechanisms behind the actions of HBO and APC on bone
repair may be different, the variables in this study showed
only a few differences between the two methods of treatment.
Although qualitative assessment highlights APC’s super-
iority to HBO in relation to the consolidation rate, further
studies should be conducted comparing the two therapies
and their effects on bone healing.
In this study, we observed that osteoblastic activity was
high in the CG during the 4th and 6th weeks but was higher
in all other groups during the 2nd week. We also observed
that osteoblastic activity was higher in the APC group than
in the HBO group during the 2nd and 4th weeks, while no
difference was found between these groups in relation to the
number of osteoblasts during the 6th and 8th weeks. These
findings corroborate previous knowledge that osteoblastic
actions are strongly associated with higher concentrations of
growth factors. We wish to note that this action was
stronger in the first weeks with APC treatment and that it
was superior to treatment with HBO at this stage.
Despite the differences observed in relation to the
osteoblastic activity among the subgroups during the first
experimental weeks, counting the number of osteocytes
during the 8th week does not indicate the quantity of newly
formed bone present in each subgroup, as advocated by
other authors (29). We believe that the number of osteocytes
associated with qualitative analysis and other variables,
such as lesion thickness and percentage of collagen, better
Table 2 - Multiple comparisons of the average percentage of collagen, average number of osteoblasts and osteocytes,
and average lesion thickness, according to groups and euthanasia periods (subgroups).
W Comparisons between groups
% of collagen (p) Lesion thickness (p) No. of osteocytes (p) No. of osteoblasts (p)
2 CG,APCG,HBOG
,APC+HBOG (,0.001)
CG.APCG.HBOG
.APCG+HBOG (,0.001)
CG=APCG=HBOG (.0.05) GC,HBOG,APCG (,0.005)
APC+HBOG.CG (0.025) APC+HBOG.CG (,0.001)
APC+HBOG=APCG=
HBOG(.0.999)
APC+HBOG=
APCG, HBOG (.0.05)
4 CG,HBOG,APCG
,APC+HBOG (,0.001)
CG.APCG.HBOG
.APC+HBOG(,0.001)
CG=APCG=HBOG (.0.05) GC.HBOG.APCG (,0.001)
APC+HBOG.CG, APCG,HBOG
(,0.001)
APC+HBOG,CG, APCG(,0.001)
APC+HBOG=HBOG (.0.999)
6 CG,APCG,HBOG
,APC+HBOG (,0.001)
CG.APCG.HBOG
.APCG+HBOG (,0.001)
CG,APCG,HBOG,APC+HBOG
(,0.05)
CG.APCG, HBOG,
APC+HBOG (,0.001)
HBOG=APCG (0.077)
APC+HBOG,APCG (,0.001)
APC+HBOG=HBOG (0.077)
8 CG,HBOG,APCG
,APC+HBOG (,0.001)
CG.APCG.HBOG
.APCG+HBOG (,0.05)
APCG=CG (0.885) CG=HBOG=APCG=APC+HBOG
(.0.999)
HBOG, APC+HBOG.CG (,0.05)
HBOG=APCG=APC+HBOG (.0.05)
W: Weeks; CG: Control Group; APCG: Autologous platelet concentrate Group; HBOG: Hyperbaric oxygen therapy Group; APC+HBOG: Autologous platelet
concentrate plus Hyperbaric oxygen therapy Group.
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suggest the quantity of newly formed bone. In this study,
APC+HBO was superior in producing a greater quantity of
new bone compared with the APC, HBO, and control
treatments during the 8th week.
The importance of this study lies in the possibility of
combining these two treatments, the effects of which
potentiate increased bone formation. Additional studies
with other variables must be conducted to deepen our
knowledge of the effects of each of these treatments on bone
healing; further studies should examine the economic
impact of these combinations.
The analysis of these outcomes allows us to state that APC
and HBO combined increased the rate of bone healing in
this experimental model. In addition, the rate of bone repair
in the groups treated with APC or HBO were similar, and
both rates were higher than in the CG.
Figure 2 - A) Photomicrograph of rabbit fibula of the CG showing the region of the lesion after 2 weeks. Note that there are many
connective tissue cells (*), blood vessels (V), and osteoblasts (arrows) (HE). B) Photomicrographs of the rabbit fibulae of the CG 6 weeks
after the injury. Note the cartilaginous tissue and small regions of cartilage calcified into newly formed bone within the tissue (arrows)
(HE). C) Photomicrograph of rabbit fibulae of the APCG 2 weeks after the injury (HE). D) Photomicrographs of the rabbit fibulae of the
ACPG after 6 weeks showing the damaged areas. Note that the bone tissue contains numerous cavities (*) (HE). E) Photomicrographs of
the rabbit fibulae of the HBOG showing the region of the lesions after 2 weeks. Note the cartilaginous tissue (straight line) (HE). F)
Photomicrographs of the rabbit fibulae of the HBOG showing the region of the lesion after 6 weeks (HE). G) Photomicrographs of the
rabbit fibulae of the APC + HBOG after 2 weeks showing the region of the injury. Note that the site of the injury is filled with cartilage
tissue (straight line) (HE). H) Photomicrographs of the rabbit fibulae of the APC + HBOG after 6 weeks showing the region of the
injuries. Note the absence of injury and the bone tissue that formed (HE). HBOGwas superior to theAPCG across all periods for this variable.
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